rs149573681

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012301.4(MAGI2):​c.893A>G​(p.Asn298Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000916 in 1,614,200 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0046 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 9 hom. )

Consequence

MAGI2
NM_012301.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0120

Publications

4 publications found
Variant links:
Genes affected
MAGI2 (HGNC:18957): (membrane associated guanylate kinase, WW and PDZ domain containing 2) The protein encoded by this gene interacts with atrophin-1. Atrophin-1 contains a polyglutamine repeat, expansion of which is responsible for dentatorubral and pallidoluysian atrophy. This encoded protein is characterized by two WW domains, a guanylate kinase-like domain, and multiple PDZ domains. It has structural similarity to the membrane-associated guanylate kinase homologue (MAGUK) family. [provided by RefSeq, Jul 2008]
MAGI2 Gene-Disease associations (from GenCC):
  • nephrotic syndrome 15
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019738674).
BP6
Variant 7-78501649-T-C is Benign according to our data. Variant chr7-78501649-T-C is described in ClinVar as Benign. ClinVar VariationId is 129556.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00465 (708/152314) while in subpopulation AFR AF = 0.0162 (672/41566). AF 95% confidence interval is 0.0152. There are 7 homozygotes in GnomAd4. There are 334 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGI2NM_012301.4 linkc.893A>G p.Asn298Ser missense_variant Exon 5 of 22 ENST00000354212.9 NP_036433.2 Q86UL8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGI2ENST00000354212.9 linkc.893A>G p.Asn298Ser missense_variant Exon 5 of 22 1 NM_012301.4 ENSP00000346151.4 Q86UL8-1

Frequencies

GnomAD3 genomes
AF:
0.00464
AC:
706
AN:
152196
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00138
AC:
346
AN:
251464
AF XY:
0.000861
show subpopulations
Gnomad AFR exome
AF:
0.0178
Gnomad AMR exome
AF:
0.00124
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000703
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000527
AC:
770
AN:
1461886
Hom.:
9
Cov.:
32
AF XY:
0.000476
AC XY:
346
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0176
AC:
590
AN:
33480
American (AMR)
AF:
0.00125
AC:
56
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000351
AC:
39
AN:
1112008
Other (OTH)
AF:
0.00109
AC:
66
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
44
87
131
174
218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00465
AC:
708
AN:
152314
Hom.:
7
Cov.:
32
AF XY:
0.00448
AC XY:
334
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0162
AC:
672
AN:
41566
American (AMR)
AF:
0.000980
AC:
15
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68030
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00190
Hom.:
5
Bravo
AF:
0.00504
ESP6500AA
AF:
0.0148
AC:
65
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00156
AC:
189
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.19
DANN
Benign
0.85
DEOGEN2
Benign
0.10
T;T;.;.;.;.;T;.;.;T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.49
N
LIST_S2
Benign
0.55
T;T;T;T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0020
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.7
.;L;L;.;.;.;.;.;.;.;.
PhyloP100
-0.012
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.7
.;N;N;.;.;.;.;N;.;.;.
REVEL
Benign
0.096
Sift
Benign
0.11
.;T;T;.;.;.;.;T;.;.;.
Sift4G
Benign
0.39
T;T;T;T;T;.;T;T;T;T;.
Polyphen
0.0030, 0.20
.;B;B;.;.;.;.;.;.;.;.
Vest4
0.14, 0.12, 0.13, 0.12, 0.14, 0.16, 0.13
MVP
0.33
MPC
0.20
ClinPred
0.0057
T
GERP RS
-8.7
Varity_R
0.033
gMVP
0.13
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149573681; hg19: chr7-78130966; API